Comparative bioavailability of neoral and sandimmune in cardiac transplant recipients over 1 year

Transplantation Proceedings

Volumn 30, Issue 5, 1998, Pages 1892-1894

  Cooney, G F ^a,c   Jeevanandam, V ^a   Choudhury, S ^b   Feutren, G ^b   Mueller, E A ^b   Eisen, H J ^a  

^a TEMPLE UNIVERSITY HOSPITAL   (United States)

^b NOVARTIS PHARMA AG   (Switzerland)

^c Novartis Pharma AG ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN A;

ADULT; AREA UNDER THE CURVE; BODY WEIGHT; CLINICAL ARTICLE; CONFERENCE PAPER; CONTROLLED STUDY; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; FEMALE; GRAFT REJECTION; HEART TRANSPLANTATION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; MALE; PRIORITY JOURNAL; TREATMENT OUTCOME;

ADMINISTRATION, ORAL; BIOLOGICAL AVAILABILITY; CYCLOSPORINE; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FOLLOW-UP STUDIES; HEART TRANSPLANTATION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INFUSIONS, INTRAVENOUS; MALE; METABOLIC CLEARANCE RATE; MIDDLE AGED; TIME FACTORS;

EID: 0031713638     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0041-1345(98)00472-2     Document Type: Conference Paper

References (12)

1. Lindholm A, Kahan BD: Clin Pharmacol Ther 54:205, 1993
2. Kahan BD, Welsh M, Schoenberg L, et al: Transplantation 62:599, 1996
3. Mueller EA, Kovarik JM, Van Bree JB, et al: Transplantation 57:1178, 1994
4. Kahan BD, Dunn J, Fitts C, et al: Transplantation 59:505, 1995
5. Keown P, Landsberg D, Halloran P, et al: Transplantation 62:1744, 1996
6. Barone G, Chang CT, Choc MG, et al: Transplantation 61:875, 1996
7. Lodge JPA, Pollard SG: Transplant Proc 29:272, 1997
8. Pollard SG, Lodge JPA: Transplant Proc 28:2214, 1996
9. Hemming AW, Greig PD, Cattral MS: Transplantation 62: 1798, 1996
10. Trull AK, Steel L, Sharples L, et al: J Heart Lung Transplant 16:45, 1997
11. Yee GC, McGuire TR: Clin Pharmacokinet 19:319, 1990
12. Lindholm A, Ohlman S, Albrechtsen D, et al: Transplantation 56:307, 1993